Page last updated: 2024-12-07
thrazarine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
thrazarine: from Streptomyces coerulescens MH802-fF5; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 129042 |
| SCHEMBL ID | 10421512 |
| MeSH ID | M0162032 |
Synonyms (12)
| Synonym |
|---|
| o-((3r)-2-diazo-3-hydroxybutyryl)-l-serine |
| l-serine, 2-diazo-3-hydroxybutanoate (ester), (r)- |
| thrazarine |
| o-(2-diazo-3-hydroxybutyryl)serine |
| fr900840 |
| 2-amino-2-carboxyethyl 2-diazo-3-hydroxybutyrate |
| fr-900840 |
| 120128-14-5 |
| SCHEMBL10421512 |
| o-((r)-2-diazo-3-hydroxybutanoyl)-l-serine |
| (2s)-2-amino-3-[(3r)-2-diazo-3-hydroxybutanoyl]oxypropanoic acid |
| AKOS040747539 |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||